超药品说明书用药目录(2018年版)

2018-05-18 广东省药学会 广东省药学会官网

5月18日,广东省药学会的官网发布了“关于印发《超药品说明书用药目录(2018年版)》的通知”。通知提到,为了更好地协助各医疗机构制定超说明书用药目录,广东省药学会循证药学专家委员会《超药品说明书用药目录》工作组组织编写了《超药品说明书用药目录(2018年版)》,共收入了98种,共计184个可超说明书使用的药品。

中文标题:

超药品说明书用药目录(2018年版)

发布机构:

广东省药学会

发布日期:

2018-05-18

简要介绍:

5月18日,广东省药学会的官网发布了“关于印发《超药品说明书用药目录(2018年版)》的通知”。通知提到,为了更好地协助各医疗机构制定超说明书用药目录,广东省药学会循证药学专家委员会《超药品说明书用药目录》工作组组织编写了《超药品说明书用药目录(2018年版)》,共收入了98种,共计184个可超说明书使用的药品。 

拓展指南:超说明书相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=超药品说明书用药目录(2018年版))] GetToolGuiderByIdResponse(projectId=1, id=f30991c00159a5f1, title=超药品说明书用药目录(2018年版), enTitle=, guiderFrom=广东省药学会官网, authorId=null, author=, summary=5月18日,广东省药学会的官网发布了“关于印发《超药品说明书用药目录(2018年版)》的通知”。通知提到,为了更好地协助各医疗机构制定超说明书用药目录,广东省药学会循证药学专家委员会《超药品说明书用药目录》工作组组织编写了《超药品说明书用药目录(2018年版)》,共收入了98种,共计184个可超说明书使用的药品。 , cover=, journalId=null, articlesId=null, associationId=1082, associationName=广东省药学会, associationIntro=广东省药学会前身为1945年成立的广州药师公会,1951年成为中国药学会广州分会。1958年在原有基础上扩大组织,成立中国药学会广东分会,负责组织全省药学科技工作者的相关活动。1985年起,中国药学会广东分会一直挂靠在广东省食品药品监督管理局(省医药管理局)。1991年,按民政部门文件要求更名为广东省药学会。, copyright=0, guiderPublishedTime=Fri May 18 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>5月18日,广东省药学会的官网发布了“关于印发《超药品说明书用药目录(2018年版)》的通知”。通知提到,为了更好地协助各医疗机构制定超说明书用药目录,广东省药学会循证药学专家委员会《超药品说明书用药目录》工作组组织编写了《超药品说明书用药目录(2018年版)》,共收入了98种,共计184个可超说明书使用的药品。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>超说明书</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=a51561c00135e81f" title="抗菌药物超说明书用法专家共识" target=_blank>抗菌药物超说明书用法专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1f7371c001353392" title="《抗菌药超说明书用法专家共识》解读" target=_blank>《抗菌药超说明书用法专家共识》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6c4271c001199ec3" title="中国儿科超说明书用药专家共识" target=_blank>中国儿科超说明书用药专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%B6%85%E8%AF%B4%E6%98%8E%E4%B9%A6" target=_blank>有关超说明书更多指南</a></ul>, tagList=[TagDto(tagId=75248, tagName=超药品说明书用药目录)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7726, appHits=146, showAppHits=0, pcHits=6275, showPcHits=1947, likes=122, shares=5, comments=3, approvalStatus=1, publishedTime=Tue May 22 22:38:32 CST 2018, publishedTimeString=2018-05-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue May 22 22:38:32 CST 2018, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 22:54:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=超药品说明书用药目录(2018年版))])
超药品说明书用药目录(2018年版)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=317712, encodeId=6cb531e712ea, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 23 06:20:57 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317663, encodeId=f46331e663c4, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed May 23 00:41:06 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317637, encodeId=9e6731e63726, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 22 23:22:44 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-23 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=317712, encodeId=6cb531e712ea, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 23 06:20:57 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317663, encodeId=f46331e663c4, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed May 23 00:41:06 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317637, encodeId=9e6731e63726, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 22 23:22:44 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-23 飛歌

    学习了很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=317712, encodeId=6cb531e712ea, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed May 23 06:20:57 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317663, encodeId=f46331e663c4, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed May 23 00:41:06 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317637, encodeId=9e6731e63726, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue May 22 23:22:44 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-22 wqkm

    ^_^^_^^_^

    0